Ruch, B.; Wagler, J.; Kumm, K.; Zhang, C.; Katariya, N.N.; Garcia-Saenz-de-Sicilia, M.; Giorgakis, E.; Mathur, A.K.
Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future. Curr. Oncol. 2022, 29, 7537-7551.
https://doi.org/10.3390/curroncol29100593
AMA Style
Ruch B, Wagler J, Kumm K, Zhang C, Katariya NN, Garcia-Saenz-de-Sicilia M, Giorgakis E, Mathur AK.
Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future. Current Oncology. 2022; 29(10):7537-7551.
https://doi.org/10.3390/curroncol29100593
Chicago/Turabian Style
Ruch, Brianna, Josiah Wagler, Kayla Kumm, Chi Zhang, Nitin N. Katariya, Mauricio Garcia-Saenz-de-Sicilia, Emmanouil Giorgakis, and Amit K. Mathur.
2022. "Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future" Current Oncology 29, no. 10: 7537-7551.
https://doi.org/10.3390/curroncol29100593
APA Style
Ruch, B., Wagler, J., Kumm, K., Zhang, C., Katariya, N. N., Garcia-Saenz-de-Sicilia, M., Giorgakis, E., & Mathur, A. K.
(2022). Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future. Current Oncology, 29(10), 7537-7551.
https://doi.org/10.3390/curroncol29100593